Dahdaleh Institute supports the call for an intellectual property waiver for COVID-19 products and technologies
October 29, 2020
The Dahdaleh Institute for Global Health Research supports the call for a COVID-19 WTO TRIPS IP waiver, as expressed in the joint statement released by the Canadian Coalition for Global Health Research and the Canadian Society for International Health, titled Improving equitable access: why an intellectual property waiver for COVID-19 products and technologies deserves global support.
In light of the above, we urge the Government of Canada, and call on other WTO member states when the TRIPS Council reconvenes to support fully this important multilateral strategy to ensure equitable access to COVID-19 products and technologies. We further call on the Government of Canada, and all other donor countries, to increase the levels of their health development assistance to countries facing health systems and procurement barriers to rapid distribution of essential medicines, vaccines and medical supplies needed to end the pandemic.
Related Content
Next/Previous
Innovative new data analytics technology to help improve access to safe water in refugee camps »
« Opportunity: Associate/Full Professor, Experiential Learning in Global Health
